Raphael Pharmaceutical Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Raphael Pharmaceutical Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • Raphael Pharmaceutical Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$326K, a 55% increase year-over-year.
  • Raphael Pharmaceutical Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$1M, a 60.1% increase year-over-year.
  • Raphael Pharmaceutical Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$1.28M, a 61.8% increase from 2022.
  • Raphael Pharmaceutical Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.36M, a 107% decline from 2021.
  • Raphael Pharmaceutical Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$1.63M, a 126% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.28M +$2.07M +61.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$3.36M -$1.73M -107% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$1.63M -$907K -126% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-05-25
2020 -$718K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.